| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/15/1993 | WO1993006864A1 Preventing allograft rejection with antibodies to adhesion molecules |
| 04/15/1993 | WO1993006863A1 Inhibition of vascular narrowing using anti-padgem antibodies |
| 04/15/1993 | WO1993006861A1 Vaccine for neisseria meningitidis infections |
| 04/15/1993 | WO1993006859A1 Sperm surface protein |
| 04/15/1993 | WO1993006856A1 Treating ophthalmic fibrosis using interferon-alpha |
| 04/15/1993 | WO1993006855A1 Hemostatic composition for local hemostasis |
| 04/15/1993 | WO1993006854A1 Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl |
| 04/15/1993 | WO1993006853A1 Cell damage repairing factor |
| 04/15/1993 | WO1993006852A2 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 04/15/1993 | WO1993006851A1 Mammalian gap-43 compositions and methods of use |
| 04/15/1993 | WO1993006850A1 Plasmodium falciparum-infected erythrocytes binding to icam-1 and cd36 |
| 04/15/1993 | WO1993006849A1 Binding of plasmodium falciparum-infected erythrocytes to cd36 |
| 04/15/1993 | WO1993006848A1 Cd36 immunoadhesins and their use in selectively killing plasmodium falciparum infected erythrocytes |
| 04/15/1993 | WO1993006847A1 Use of ifn-gamma for the treatment of infections in transplant recipients |
| 04/15/1993 | WO1993006846A1 Parathyroid hormone analogues and use in osteoporosis treatment |
| 04/15/1993 | WO1993006845A1 PARATHYROID HORMONE ANALOGUES SUBSTITUTED AT aa?25,26,27¿ AND USE IN OSTEOPOROSIS TREATMENT |
| 04/15/1993 | WO1993006844A1 Hormone analogs with multiple ctp extensions |
| 04/15/1993 | WO1993006842A1 Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma |
| 04/15/1993 | WO1993006841A1 A peptide analog |
| 04/15/1993 | WO1993006839A1 Method for enhancing gut absorption |
| 04/15/1993 | WO1993006836A1 Von willebrand factor-specific heparin fractions |
| 04/15/1993 | WO1993006835A1 Leukocyte adhesion molecule-1 (lam-1) and ligand thereof |
| 04/15/1993 | WO1993006812A2 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 04/15/1993 | WO1993006791A1 Collagen constructs |
| 04/15/1993 | WO1993004710A3 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone |
| 04/15/1993 | DE4133694A1 Verwendung einer emulsion, zur herstellung eines arzneimittels zur iv-verabreichung zur behandlung von hauterkrankungen Use of an emulsion, for the manufacture of a medicament for intravenous administration for the treatment of skin diseases |
| 04/15/1993 | CA2121028A1 Hemostatic composition for local hemostasis |
| 04/15/1993 | CA2120950A1 Treating ophthalmic fibrosis using interferon-alpha |
| 04/15/1993 | CA2120946A1 Parathyroid hormone analogues substituted at aa 25.26.27 and use in osteoporosis treatment |
| 04/15/1993 | CA2120755A1 Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl |
| 04/15/1993 | CA2120707A1 Human il-3 variants |
| 04/15/1993 | CA2120601A1 Sperm surface protein |
| 04/15/1993 | CA2120500A1 Preventing allograft rejection with antibodies to adhesion molecules |
| 04/15/1993 | CA2120362A1 Cyclic compounds useful as inhibitors of platelet glycoprotein iib/iiia |
| 04/15/1993 | CA2120240A1 Inhibition of vascular narrowing using anti-padgen antibodies |
| 04/15/1993 | CA2119580A1 Production of gpa neurotrophic factor |
| 04/15/1993 | CA2097056A1 Vaccine against neisseria meningitidis infections |
| 04/15/1993 | CA2096411A1 Subunit vaccine for neisseria meningitidis infections and corresponding purified subunits |
| 04/14/1993 | EP0536807A1 Monoclonal antibodies and their use |
| 04/14/1993 | EP0536805A1 Lactoferrin hydrolyzate for use as a tyrosinase inhibition agent |
| 04/14/1993 | EP0536741A2 Cyclic VIP analogs |
| 04/14/1993 | EP0536566A1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 04/14/1993 | EP0536563A1 Nuclear inhibitor I-92 and its use for the production of a medicament |
| 04/14/1993 | EP0536520A1 Human interferon beta 2A containing pharmaceuticals |
| 04/14/1993 | EP0536343A1 Targeted polymeric conjugates of cyclosporin and method for their preparation. |
| 04/14/1993 | EP0536335A1 Compositions and methods for the prevention and diagnosis of lyme disease |
| 04/14/1993 | EP0536322A1 HUMAN MACROPHAGE INFLAMMATORY PROTEIN 2$g(a) |
| 04/14/1993 | EP0536317A1 Mast cell growth factor |
| 04/14/1993 | EP0536299A1 Surface complexed lymphotoxin |
| 04/14/1993 | EP0536275A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 04/14/1993 | EP0536245A1 Novel, protracted insulin analogues |
| 04/14/1993 | EP0536234A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof |
| 04/14/1993 | EP0536215A1 Neurofibromatosis gene |
| 04/14/1993 | EP0536213A1 Sexe determining gene |
| 04/14/1993 | EP0536186A1 Bone and cartilage inductive proteins |
| 04/14/1993 | EP0536177A1 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 04/14/1993 | EP0437478B1 Cyclodextrin-peptide complexes |
| 04/14/1993 | EP0380546B1 Polypeptides with type iv collagen activity |
| 04/14/1993 | CN1070946A Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 04/14/1993 | CN1020253C Pasteurization for immunoglobulin solution |
| 04/13/1993 | US5202428 DNA encoding neurotropic growth factor |
| 04/13/1993 | US5202426 Eucaryotic NAD cyclases |
| 04/13/1993 | US5202424 Mesangial cell-derived receptors for advanced glycosylation endproducts and uses thereof |
| 04/13/1993 | US5202422 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |
| 04/13/1993 | US5202421 Anticoagulant substance obtained from urine and process for the preparation thereof |
| 04/13/1993 | US5202420 Pure genetically engineered peptides which inhibit growth of escherichia |
| 04/13/1993 | US5202419 Anticoagulative protein pp4-x |
| 04/13/1993 | US5202415 Having 29 first amino acids of B chain of human insulin linked to 21 amino acids of A chain by specified amino acids |
| 04/13/1993 | US5202352 Antitumor agents |
| 04/13/1993 | US5202312 Antiarthritic agents, antiallergens, antidiabetic agents |
| 04/13/1993 | US5202311 Fibroblast growth factor stabilized with salt of sucrose octasulfate |
| 04/13/1993 | US5202310 Cyclosporine metabolites |
| 04/13/1993 | US5202309 Antibiotic cyclopeptide fermentation product |
| 04/13/1993 | US5202253 Activation by calcium compounds |
| 04/13/1993 | US5202252 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction |
| 04/13/1993 | US5202241 Spectrum analysis of physiochemical and biological properties; useful in treatment of infection diseases involving microorganism susceptible to them; culture product |
| 04/13/1993 | US5202121 Thrombolytic compositions |
| 04/13/1993 | US5202119 Administering somatomedins |
| 04/13/1993 | US5202118 Applying interleukins in hydrophilic carriers to injuries, burns, pressure sores |
| 04/13/1993 | US5202117 Method of treating thrombi with g-csf |
| 04/13/1993 | US5202116 Supression of cytokine-stimulated expression of MHC antigens |
| 04/13/1993 | US5202113 Plaque-inhibiting protein from bacteroides loeschei and methods for using the same |
| 04/13/1993 | CA1316132C Cdna and gene for human angiogenin (angiogenesis factor) and method of expression |
| 04/13/1993 | CA1316105C Stable interferon complexes |
| 04/12/1993 | WO1993006862A1 Antibody composition |
| 04/12/1993 | CA2097932A1 Antibody containing composition |
| 04/11/1993 | CA2080110A1 Organic compounds |
| 04/10/1993 | WO1993006840A1 Medicine for preventing and treating bleeding tendency |
| 04/10/1993 | CA2098008A1 Agent for preventing or treating hemorrhage tendency |
| 04/08/1993 | DE4133189A1 Natural antiinflammatory agents - comprises fluid secreted after inducing cutaneous allergic reaction |
| 04/07/1993 | EP0535968A1 Cyclohexapeptidyl hydroxypropionitrile compounds |
| 04/07/1993 | EP0535967A2 Cyclohexapeptidyl bisamine compounds |
| 04/07/1993 | EP0535959A1 Cyclohexapeptidyl propanolamine compounds |
| 04/07/1993 | EP0535899A1 Injectable extended release formulations and methods |
| 04/07/1993 | EP0535827A1 Calcitonin suspensions for oral administration |
| 04/07/1993 | EP0535804A1 Peptide compounds |
| 04/07/1993 | EP0535731A2 Inhibitors of farnesyl protein transferase |
| 04/07/1993 | EP0535730A2 Inhibitors of farnesyl protein transferase |
| 04/07/1993 | EP0535723A1 Buffered formulation of capitals |
| 04/07/1993 | EP0535337A2 Cell growth inhibiting activities of heparin binding neurite-outgrowth promoting factor |